51167-770 : Kalydeco 13.4 mg Oral Granule


NDC: 51167-770
Labeler: Vertex Pharmaceuticals Incorporated
Product Type: Human Prescription Drug
Drug Name:  Kalydeco
Dosage Form: Oral Granule
Application #: NDA207925
Rev. Date: 


NDC Package Codes:

  • 51167-770-01: 56 GRANULE IN 1 CARTON (51167‑770‑01)

Active Ingredients:

  • Ivacaftor

Dosage Strength:

  • 13.4 mg

Pharmaceutical Classes:

  • Chloride Channel Activation Potentiators [MoA]
  • Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]
  • Cytochrome P450 2C9 Inhibitors [MoA]
  • Cytochrome P450 3A Inhibitors [MoA]
  • P-Glycoprotein Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 51167-200 Kalydeco 150 mg Oral Tablet by Vertex Pharmaceuticals Incorporated
  • 51167-300 Kalydeco 50 mg Oral Granule by Vertex Pharmaceuticals Incorporated
  • 51167-400 Kalydeco 75 mg Oral Granule by Vertex Pharmaceuticals Incorporated
  • 51167-600 Kalydeco 25 mg Oral Granule by Vertex Pharmaceuticals Incorporated
  • 51167-785 Kalydeco 5.8 mg Oral Granule by Vertex Pharmaceuticals Incorporated

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 51167-770 QR Code

< Prev: 51167-700Next: 51167-785 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.